Sue Huang (scientist)
Sue Huang | |
|---|---|
| Other names | Qiu Sue Huang |
| Awards | Shorland Medal, Fellow of the Royal Society Te Apārangi |
| Academic background | |
| Alma mater | University of Pennsylvania |
| Academic work | |
| Institutions | Institute of Environmental Science and Research |
Qiu Sue Huang FRSNZ is a New Zealand virologist, and works at the Institute of Environmental Science and Research (ESR). She is an expert on influenza and polio viruses, and leads the Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) programme. In 2025 Huang was elected a Fellow of the Royal Society Te Apārangi.
Academic career
Huang completed a PhD titled Development of herpes simplex virus type-1 as an efficient vector for foreign gene expression in the nervous system at the University of Pennsylvania in 1995.[1] Huang is an expert on influenza and polio viruses.[2] She is the director of the World Health Organisation National Influenza Centre at the Institute of Environmental Science and Research, and leads the Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS) programme.[2][3][4] The SHIVERS programme was awarded the Royal Society Te Apārangi's Shorland Medal in 2020.[5]
In March 2025 Huang was elected a Fellow of the Royal Society Te Apārangi, for "her innovative and cutting-edge surveillance and research programmes on influenza virus, immunity, and vaccines".[2]
Selected works
- A Danielle Iuliano; Katherine M Roguski; Howard H Chang; et al. (13 December 2017). "Estimates of global seasonal influenza-associated respiratory mortality: a modelling study". The Lancet. doi:10.1016/S0140-6736(17)33293-2. ISSN 0140-6736. PMC 5935243. PMID 29248255. Wikidata Q46876629.
{{cite journal}}:|author26=has generic name (help) - Fatimah S Dawood; A Danielle Iuliano; Carrie Reed; et al. (September 2012). "Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study". Lancet Infectious Diseases. 12 (9): 687–95. doi:10.1016/S1473-3099(12)70121-4. ISSN 1473-3099. PMID 22738893. Wikidata Q28269717.
- You Li; Xin Wang; Dianna M Blau; et al. (28 May 2022). "Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis". The Lancet. 399 (10340): 2047–2064. doi:10.1016/S0140-6736(22)00478-0. ISSN 0140-6736. PMC 7613574. PMID 35598608. Wikidata Q116170707.
- ; Tim Wood; Lauren Jelley; et al. (13 November 2020), Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand, doi:10.1101/2020.11.11.20228692, PMC 7668762, PMID 33200149, Wikidata Q102129769
- M G Baker; N Wilson; ; et al. (27 August 2009). "Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009". Eurosurveillance. 14 (34): 127–136. doi:10.2807/ESE.14.34.19319-EN. ISSN 1025-496X. PMID 19712648. Wikidata Q30380176.
- Richard Hall; Jing Wang; Angela K Todd; et al. (13 September 2013). "Evaluation of rapid and simple techniques for the enrichment of viruses prior to metagenomic virus discovery". Journal of Virological Methods. 195: 194–204. doi:10.1016/J.JVIROMET.2013.08.035. ISSN 0166-0934. PMID 24036074. Wikidata Q38137615.
References
- ^ Huang, Qiu Sue (1995). Development of herpes simplex virus type-1 as an efficient vector for foreign gene expression in the nervous system (PhD). University of Pennsylvania.
- ^ a b c "Latest cohort of Ngā Ahurei a Te Apārangi Fellows announced". Royal Society Te Apārangi. Retrieved 27 March 2025.
- ^ "What is Influenza A?". NZ Herald. 27 March 2025. Retrieved 27 March 2025.
- ^ "ESR flu study findings a world first". www.esr.cri.nz. Retrieved 27 March 2025.
- ^ "The 'SHIVERS' flu study wins national science award". New Zealand Doctor. 5 June 2025. Retrieved 27 March 2025.
External links
- First flu for two years: cases on the rise, interview with Huang on Radio New Zealand Nine to Noon, 23 May 2022